Creative Medical Technology Holdings (CELZ) Receives a Buy from Roth MKM
I'm LongbridgeAI, I can summarize articles.Roth MKM analyst Jonathan Aschoff maintained a Buy rating on Creative Medical Technology Holdings (CELZ) with a $20.00 price target. The analyst consensus for CELZ is also a Moderate Buy, averaging a $20.00 target. Aschoff covers the Healthcare sector and has an average return of -19.9%.
In a report released today, Jonathan Aschoff from Roth MKM maintained a Buy rating on Creative Medical Technology Holdings, with a price target of $20.00.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Aschoff is an analyst with an average return of -19.9% and a 29.77% success rate. Aschoff covers the Healthcare sector, focusing on stocks such as GeoVax Labs, Medicus Pharma Ltd, and Creative Medical Technology Holdings.
Currently, the analyst consensus on Creative Medical Technology Holdings is a Moderate Buy with an average price target of $20.00.